BackClarity Pharmaceuticals Overview

Clarity Pharmaceuticals Other Current Assets

Latest other current assets for CU6.AX: $7.4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$7.41M
↑ 16.01% YoYΔ $1.02M vs prior year quarter

Peer average / median

Loading

Clarity Pharmaceuticals Other Current Assets History

Loading

Clarity Pharmaceuticals vs. peers: Other Current Assets Comparison

Loading

Clarity Pharmaceuticals Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clarity Pharmaceuticals (CU6.AX) FAQ

Clarity Pharmaceuticals posts a other current assets of $7.4M as of June 2026. That compares with $6.4M in the prior-year period — up 16.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Clarity Pharmaceuticals's other current assets was $6.4M. The latest reading is $7.4M — a 16.0% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Assets is one piece of Clarity Pharmaceuticals's financial statement story. At $7.4M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CU6.AX's other current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Clarity Pharmaceuticals's other metric pages and overview cover the third.

Questions & Answers